News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Recordings for Global Cancer Research and Control Seminar Series 2024 are now available – NCI
NCI /LinkedIn
Dec 7, 2024, 19:37

Recordings for Global Cancer Research and Control Seminar Series 2024 are now available – NCI

NCI Center for Global Health posted on LinkedIn:

“Thank you to everyone who came to our Global Cancer Research and Control Seminar Series in 2024! Recordings for all 2024 seminars are now available.

Stay tuned for for more information about an exciting new lineup for 2025!”

cancer Global Cancer Research and Control Seminar Series NCI Center for Global Health OncoDaily Oncology
Special Coverage
Insight
Jun 1, 2025, 14:41
Aakash Desai: Interim Results from Our Phase 1 Trial of PDL1V, a Vedotin-Based ADC Targeting PD-L1 in R/R NSCLC at ASCO 2025
Blog
Jun 1, 2025, 14:39
Christina Ip-Toma: Integrating germline and tumor genetic results to reduce disparities in cancer care
Blog
Jun 1, 2025, 14:38
Key Insights by Petros Grivas from ASCO25
Science
Jun 1, 2025, 14:38
Kriti Mittal: The ASCO special edition of the ASPIRE CoP newsletter
Oncolibrary
Jun 1, 2025, 13:48
Romiplostim for Chemotherapy-induced Thrombocytopenia Results from global phase iii trial in Gi cancers
Opinion
Jun 1, 2025, 13:42
Efficacy of IL-6R Blockade with Sarilumab in a Quadruple Immuno-Oncology Regimen for Patients with Unresectable Stage III/IV Melanoma
Oncolibrary
Jun 1, 2025, 13:02
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Oncolibrary
Jun 1, 2025, 12:40
Metacure Cohorts B2 Results: Intensified Hormonal Blockade and SBRT for PSMA-PET Detected Oligometastatic Prostate Adenocarcinoma
Oncolibrary
Jun 1, 2025, 12:03
EV-302 Updates at ASCO 2025: Enfortumab Vedotin Plus Pembrolizumab Doubles Complete Response Rate in Advanced Urothelial Carcinoma
Oncolibrary
Jun 1, 2025, 11:55
Tagitanlimab Boosts Chemotherapy in Nasopharyngeal Cancer: Phase 3 Results at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:51
FIRE-4 Study Results: Cetuximab Re-challenge in Metastatic RAS Wild-Type Colorectal Cancer
Oncolibrary
Jun 1, 2025, 11:45
Combining Darolutamide and Goserelin: A New Frontier in Fighting Salivary Gland Cancer at ASCO 2025